tiprankstipranks
Gracell Biotechnologies (GRCL)
NASDAQ:GRCL
US Market

Gracell Biotechnologies (GRCL) Ownership - Who Owns Gracell Biotechnologies?

134 Followers

Gracell Biotechnologies (GRCL) Ownership Overview

0.00%2.55%54.31%43.14%
0.00%
Insiders
54.31% Other Institutional Investors
43.14% Public Companies and
Individual Investors
The ownership structure of Gracell Biotechnologies (GRCL) stock is a mix of institutional, retail and individual investors. Approximately 56.86% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 43.14% is owned by Public Companies and Individual Investors.
The ownership structure of Gracell Biotechnologies (GRCL) stock is a mix of institutional, retail and individual investors. Approximately 56.86% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 43.14% is owned by Public Companies and Individual Investors.

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2023Bought$20883200

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,080,000Institution2.15%21,320,000
1,336,443Institution1.38%13,698,541
1,010,815Institution1.05%10,360,854
71,758Institution0.07%735,520
66,578Institution0.07%682,425
43,334Institution0.04%444,174
4,746Institution<0.01%48,647
2,806Institution<0.01%28,762
222Institution<0.01%2,276

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,336,443Institution1.38%13,698,541
1,010,815Institution1.05%10,360,854
66,578Institution0.07%682,425
43,334Institution0.04%444,174
4,746Institution<0.01%48,647

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
35,879Institution0.04%367,760
2,806Institution<0.01%28,762
222Institution<0.01%2,276

FAQ

Who Owns Gracell Biotechnologies (GRCL)?
According to the latest TipRanks data, approximately 54.31% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 43.14% is held by retail investors.
    What percentage of Gracell Biotechnologies (GRCL) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 54.31% of Gracell Biotechnologies (GRCL) stock is held by institutional investors.
      What percentage of Gracell Biotechnologies (GRCL) stock is held by retail investors?
      According to the latest TipRanks data, approximately 43.14% of Gracell Biotechnologies (GRCL) stock is held by retail investors.
        Who owns the most shares of Gracell Biotechnologies (GRCL)?
        Felix Baker owns the most shares of Gracell Biotechnologies (GRCL).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis